Advanced analytical techniques for testing generic orally inhaled and nasal drug products
How to build confidence in the in-vitro data for your generic product.

Our expert, Chris Vernall, Business Development Director, covered a range of technologies during this session:

  • The use and significance of real breathing profiles for emitted dose and impactor testing of OINDPs
  • The use of Morphologically Directed Raman Spectroscopy (MDRS) to determine insitu PSD for powder and suspension formulations.
  • Advanced lung dissolution models
  • How to use the above tools in conjunction with conventional IV-BE tests to avoid costly failures in the clinic
  • What else can we add to move towards true 'IV-IVC'?

Please complete the form below to access the recording.